Company · CIK 0001806952
Lyell Immunopharma, Inc.
LYELSearch this company’s filings
Search features10 guest searches · Free accounts get 10 a day · No credit card
Market data
Price
$8.71−$0.08 (−0.910%)
LYEL · Last trade
- Prev close
- $8.79
- Range (29d)
- $8.56 – $12.20
On the record
Recent filings
- 8-KLYELCurrent report0001193125-26-387890 · 161.2 KBSEC(opens sec.gov)
- SCHEDULE 13G/ALYELLyell Immunopharma, Inc.0001104659-26-097073 · 21.4 KBSEC(opens sec.gov)
- 10-QLYELQuarterly update0001628280-26-054367 · 11.4 MBSEC(opens sec.gov)
- 8-KLYELCurrent report0001628280-26-054330 · 321.8 KBSEC(opens sec.gov)
- 8-KLYELCurrent report0001193125-26-271071 · 147.6 KBSEC(opens sec.gov)
- 10-QLYELQuarterly update0001628280-26-031284 · 10.5 MBSEC(opens sec.gov)
- 8-KLYELCurrent report0001628280-26-031269 · 291.0 KBSEC(opens sec.gov)
- 10-KLYELAnnual report0001628280-26-017253 · 18.8 MBSEC(opens sec.gov)
- 8-KLYELCurrent report0001628280-26-017244 · 291.4 KBSEC(opens sec.gov)
- 8-KLYELCurrent report0001193125-26-097615 · 200.9 KBSEC(opens sec.gov)
Insiders
- Aguirre Jarrad MattieuChief Medical Officer
- Albertson Tina M.Chief Medical Officer
- ARCH Venture Fund IX, L.P.10% Owner
- ARCH Venture Fund XIII, L.P.10% Owner
- ARCH Venture Partners IX, LLC10% Owner
- ARCH Venture Partners IX, L.P.10% Owner
- Bachleda MarkDirector
- BERNS PAUL L10% Owner
- Bishop Hans EdgarDirector
- BRAWLEY OTIS WDirector
Tickers
Addresses
business
201 HASKINS WAY
SOUTH SAN FRANCISCO, CA, 94080
mailing
201 HASKINS WAY
SOUTH SAN FRANCISCO, CA, 94080
Same industry